Use of oligouronates for treating mucus hyperviscosity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8754063
APP PUB NO 20090010914A1
SERIAL NO

12089529

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of treatment of a human or non-human subject to combat mucosal hyperviscosity in the respiratory tract, which method includes application to a mucosal surface in the tract in the subject of an effective amount of a physiologically tolerable oligouronate. Related compositions containing physiologically tolerable oligouronates are also described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NTNU TECHNOLOGY TRANSFER ASKLAEBUVEIEN 153 TRONDHEIM N-7491

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Draget, Kurt Ingar Trondheim, NO 29 90
Smidsrod, Olav Asmund Trondheim, NO 3 19
Taylor, Catherine Trondheim, NO 26 125

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 17, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00